1. Home
  2. GMEX vs PFSA Comparison

GMEX vs PFSA Comparison

Compare GMEX & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GMEX

GMEX ROBOTICS CORPORATION Class A Ordinary Shares

N/A

Current Price

$1.93

Market Cap

1.7M

ML Signal

N/A

PFSA

Profusa Inc.

HOLD

Current Price

$0.37

Market Cap

2.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMEX
PFSA
Founded
2005
2009
Country
Australia
United States
Employees
16
N/A
Industry
Recreational Games/Products/Toys
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
2.0M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GMEX
PFSA
Price
$1.93
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.5M
437.6K
Earning Date
04-17-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.05
52 Week High
$2.50
$4.22

Technical Indicators

Market Signals
Indicator
GMEX
PFSA
Relative Strength Index (RSI) 60.83 36.11
Support Level $1.44 $0.28
Resistance Level $2.10 $0.41
Average True Range (ATR) 0.30 0.04
MACD -0.01 0.00
Stochastic Oscillator 44.18 9.25

Price Performance

Historical Comparison
GMEX
PFSA

About GMEX GMEX ROBOTICS CORPORATION Class A Ordinary Shares

GMEX Robotics Corp is engaged in the design and deployment of AI-powered robotics and intelligent consumer technologies. The group operates in three business areas: Consumer and Commercial Robotics: Developing intuitive and interactive robots designed to assist with daily tasks, provide smart home integration, and offer new levels of convenience and connectivity to boost productivity; AI-Driven Hardware: Embedding artificial intelligence into physical products to create self-learning and adaptive user experiences; and Innovation & Ecosystem: Building a robust ecosystem of robotic products that communicate and evolve, powered by proprietary AI algorithms.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

Share on Social Networks: